{"id":58129,"date":"2025-11-06T11:16:20","date_gmt":"2025-11-06T11:16:20","guid":{"rendered":"https:\/\/ibima.eu\/?page_id=58129"},"modified":"2025-11-27T09:25:05","modified_gmt":"2025-11-27T09:25:05","slug":"ep-permed-carmen2026","status":"publish","type":"page","link":"https:\/\/ibima.eu\/es\/ep-permed-carmen2026\/","title":{"rendered":"EP PerMed &#8211; CARMEN2026"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbsection\u00bb _builder_version=\u00bb4.25.1&#8243; custom_padding=\u00bb||0px|||\u00bb locked=\u00bboff\u00bb collapsed=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_5,3_5,1_5&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb21px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2025\/09\/EPPerMed_Logo_.png\u00bb title_text=\u00bbEPPerMed_Logo_\u00bb align=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb54%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb26px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb59px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbEP PerMed \u2013 Personalised Medicine for CARdiovascular, MEtabolic and kidNey diseases (CARMEN2026)\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_text_align=\u00bbcenter\u00bb title_text_color=\u00bb#0C71C3&#8243; title_line_height=\u00bb1.3em\u00bb module_alignment=\u00bbcenter\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb20px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.4&#8243; header_text_color=\u00bb#000000&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb custom_margin=\u00bb1px|-78px|||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<p style=\"text-align: justify;\">La Asociaci\u00f3n Europea EP PerMed ha lanzado la convocatoria transnacional <strong>CARMEN2026<\/strong>, destinada a financiar proyectos de investigaci\u00f3n innovadora en medicina personalizada en el \u00e1mbito de las <strong>enfermedades cardiovasculares, metab\u00f3licas y renales<\/strong>, apoyada por la Uni\u00f3n Europea a trav\u00e9s de Horizon Europe.<\/p>\n<p style=\"text-align: justify;\">Esta iniciativa tiene como objetivo impulsar la competitividad europea mediante proyectos colaborativos que integren equipos acad\u00e9micos, cl\u00ednicos, de salud p\u00fablica y del sector privado.<\/p>\n<p>[\/et_pb_text][et_pb_heading title=\u00bbObjetivos de la convocatoria\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb20px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=\u00bbrow\u00bb _builder_version=\u00bb4.25.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb77.1%\u00bb custom_margin=\u00bb|-259px||161px||\u00bb custom_padding=\u00bb|0px||9px||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.4&#8243; header_text_color=\u00bb#000000&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb custom_margin=\u00bb11px|-78px|||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<p style=\"text-align: justify;\">Los proyectos deber\u00e1n centrarse en <strong>salud humana<\/strong> y abordar estrategias innovadoras de medicina personalizada para pacientes con enfermedades cardiovasculares, metab\u00f3licas o renales. Los proyectos de investigaci\u00f3n pueden centrarse en una sola enfermedad o explorar estas afecciones en combinaci\u00f3n. Las propuestas deber\u00e1n abordar uno o m\u00e1s de los siguientes aspectos:<\/p>\n<ul>\n<li data-start=\"472\" data-end=\"797\" style=\"text-align: justify;\">Desarrollo y validaci\u00f3n de enfoques terap\u00e9uticos personalizados innovadores para enfermedades cardiovasculares, metab\u00f3licas o renales mediante <strong>pruebas en modelos precl\u00ednicos relevantes<\/strong>.<\/li>\n<li data-start=\"472\" data-end=\"797\" style=\"text-align: justify;\">Identificaci\u00f3n y validaci\u00f3n de marcadores o firmas moleculares, o tecnolog\u00edas de vanguardia, para <strong>monitorizar la respuesta al tratamiento<\/strong> en pacientes con enfermedades cardiovasculares, metab\u00f3licas o renales con el fin de adaptar las v\u00edas terap\u00e9uticas.<\/li>\n<li data-start=\"472\" data-end=\"797\" style=\"text-align: justify;\">Identificaci\u00f3n y validaci\u00f3n de marcadores o firmas moleculares de estratificaci\u00f3n, o tecnolog\u00edas de diagn\u00f3stico de estratificaci\u00f3n, para la <strong>predicci\u00f3n temprana del riesgo<\/strong> de enfermedad y la prevenci\u00f3n del empeoramiento, retrasando as\u00ed la progresi\u00f3n <strong>hacia el s\u00edndrome cardio\u2013renal\u2013metab\u00f3lico<\/strong>.<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb10px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbAspectos a tener en cuenta\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb min_height=\u00bb88px\u00bb custom_padding=\u00bb||0px|11px||\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<ul>\n<li data-start=\"142\" data-end=\"450\">\n<p data-start=\"145\" data-end=\"450\" style=\"text-align: justify;\"><strong data-start=\"145\" data-end=\"167\">Datos multi-\u00f3micos <\/strong>en relaci\u00f3n con los resultados del tratamiento. Estos datos pueden obtenerse de plataformas o infraestructuras de datos sanitarios, incluidos bases de datos de salud a nivel poblacional.<\/p>\n<\/li>\n<li data-start=\"452\" data-end=\"832\" style=\"text-align: justify;\">\n<p data-start=\"455\" data-end=\"832\"><strong>Cutting-edge technologies<\/strong>, como algoritmos de IA\/ML, tecnolog\u00edas de imagen de nueva generaci\u00f3n, herramientas de salud digital, etc.<\/p>\n<\/li>\n<li data-start=\"834\" data-end=\"1024\" style=\"text-align: justify;\">\n<p data-start=\"837\" data-end=\"1024\"><strong data-start=\"837\" data-end=\"885\">Informaci\u00f3n sobre la medicaci\u00f3n del paciente<\/strong>, dosis o adherencia, eficacia de la medicaci\u00f3n, efectos adversos, resultados reportados por el paciente o preferencias del paciente.<\/p>\n<\/li>\n<li data-start=\"1026\" data-end=\"1159\">\n<p data-start=\"1029\" data-end=\"1159\" style=\"text-align: justify;\"><strong data-start=\"1029\" data-end=\"1053\">Factores adicionales<\/strong>, como la dimensi\u00f3n de sexo\/g\u00e9nero, edad, entorno social y ambiental, estilo de vida o estado nutricional.<\/p>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb14px|auto|-13px|159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbCondiciones generales\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243; custom_margin=\u00bb|-44px||||\u00bb width=\u00bb103.7%\u00bb]<\/p>\n<ul>\n<li style=\"text-align: justify;\">Pa\u00edses participantes: Austria, B\u00e9lgica (Flandes), B\u00e9lgica (Federaci\u00f3n Valona-Bruselas), Rep\u00fablica Checa, Dinamarca, Estonia, Finlandia, Finlandia, Francia, Alemania, Alemania, Alemania (Sajonia), Grecia, Hungr\u00eda, Islandia, Irlanda, Israel, Israel, Italia, Italia (Lombard\u00eda), Italia (Toscana), Letonia, Lituania, Luxemburgo, Noruega, Polonia, Portugal, Portugal (Azores), Portugal (Regi\u00f3n Centro), Ruman\u00eda, Rep\u00fablica Eslovaca, Sud\u00e1frica, Espa\u00f1a, Espa\u00f1a (Andaluc\u00eda), Espa\u00f1a (Catalu\u00f1a), Espa\u00f1a (Navarra), Suecia, Pa\u00edses Bajos, Turqu\u00eda.<br \/>El consorcio deber\u00e1 contar con<span style=\"font-size: 14px;\">\u00a0<\/span><strong style=\"font-size: 14px;\">un m\u00ednimo de 3 socios de 3 pa\u00edses distintos y un m\u00e1ximo de 6 socios (bajo ciertas condiciones podr\u00eda llegar a 7)<\/strong><span style=\"font-size: 14px;\">.<\/span><\/li>\n<li style=\"text-align: justify;\">Podr\u00e1n participar un socio con financiaci\u00f3n propia, siempre que aporten valor a\u00f1adido.<\/li>\n<li style=\"text-align: justify;\">Se valorar\u00e1 positivamente que los consorcios tengan al menos un socio academico, un socio cl\u00ednico y un socio industria.<\/li>\n<li style=\"text-align: justify;\">Se valorar\u00e1 positivamente integrar al menos a un investigador considerado <strong data-start=\"129\" data-end=\"164\">\u201cEarly Career Researcher\u201d (ECR)<\/strong> como investigador principal (IP) de uno de los socios del proyecto. Se consideran ECR aquellos que hayan obtenido su primer PhD o MD entre 2 y 7 a\u00f1os antes de la convocatoria, con posibles extensiones por maternidad, paternidad, enfermedad prolongada, formaci\u00f3n cl\u00ednica o servicio nacional. El periodo m\u00e1ximo de elegibilidad no puede superar los 11 a\u00f1os y 6 meses desde la obtenci\u00f3n del PhD\/MD.<br \/>Duraci\u00f3n m\u00e1xima del proyecto:<span style=\"font-size: 14px;\">\u00a0<\/span><strong style=\"font-size: 14px;\">36 meses<\/strong><span style=\"font-size: 14px;\">.<\/span><\/li>\n<li style=\"text-align: justify;\"><strong>Networking<\/strong>: se habilitar\u00e1 una plataforma y se organizar\u00e1 un evento de<span>\u00a0<\/span><em>matchmaking<\/em>. Registro en: <a href=\"https:\/\/www.b2match.com\/e\/eppermed-partnering\">https:\/\/www.b2match.com\/e\/eppermed-partnering<\/a>\n<ul><\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb min_height=\u00bb317px\u00bb custom_margin=\u00bb20px|auto||159px|false|false\u00bb custom_padding=\u00bb||0px|||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbfechas clave\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<ul>\n<li data-start=\"100\" data-end=\"161\" style=\"text-align: justify;\"><strong data-start=\"116\" data-end=\"136\">25 November 2025<\/strong> \u2013 Publication of the call<\/li>\n<li data-start=\"100\" data-end=\"161\" style=\"text-align: justify;\"><strong data-start=\"167\" data-end=\"187\">16 December 2025<\/strong> \u2013 Information Day<\/li>\n<li data-start=\"100\" data-end=\"161\" style=\"text-align: justify;\"><strong data-start=\"210\" data-end=\"242\">10 February 2026 (14:00 CET)<\/strong> \u2013 Deadline for pre-proposal submission<\/li>\n<li data-start=\"100\" data-end=\"161\" style=\"text-align: justify;\"><strong data-start=\"286\" data-end=\"308\">Around 05 May 2026<\/strong> \u2013 Communication of pre-proposal assessment results and invitation to the full proposal stage<\/li>\n<li data-start=\"100\" data-end=\"161\" style=\"text-align: justify;\"><strong data-start=\"406\" data-end=\"435\">09 June 2026 (14:00 CEST)<\/strong> \u2013 Deadline for full proposal submission<\/li>\n<li data-start=\"100\" data-end=\"161\" style=\"text-align: justify;\"><strong data-start=\"480\" data-end=\"506\">Mid\/End of August 2026<\/strong> \u2013 Rebuttal stage<\/li>\n<li data-start=\"100\" data-end=\"161\" style=\"text-align: justify;\"><strong data-start=\"605\" data-end=\"647\">24 de agosto \u2013 4 de septiembre de 2026<\/strong>: Etapa de r\u00e9plica \/ Rebuttal<\/li>\n<li data-start=\"100\" data-end=\"161\" style=\"text-align: justify;\"><strong data-start=\"528\" data-end=\"555\">October 2026 (expected)<\/strong> \u2013 Communication of funding decisions to applicants<\/li>\n<li data-start=\"100\" data-end=\"161\" style=\"text-align: justify;\"><strong data-start=\"611\" data-end=\"646\">End of 2026 \/ Beginning of 2027<\/strong> \u2013 Expected project start (according to regional\/national funding regulations)<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul><\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb-23px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbDocumentaci\u00f3n y enlaces clave\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb|||11px||\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a data-start=\"6418\" data-end=\"6458\" class=\"decorated-link\" href=\"https:\/\/www.eppermed.eu\/funding-projects\/calls\/jtc2026\/\">Web EP PerMed &#8211; CARMEN 2026<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a data-start=\"6418\" data-end=\"6458\" class=\"decorated-link\" href=\"https:\/\/www.eppermed.eu\/funding-projects\/calls\/jtc2026\/\"><\/a><a href=\"https:\/\/www.eppermed.eu\/wp-content\/uploads\/EPPerMed_JTC2026_CARMEN_Call-Text.pdf\">Texto de la convocatoria<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a href=\"https:\/\/www.eppermed.eu\/wp-content\/uploads\/EPPerMed_RITC_MultiPMData2026_call-text_FV.pdf\"><\/a><a href=\"https:\/\/www.eppermed.eu\/wp-content\/uploads\/EPPerMed_JTC2026_CARMEN2026_GuidelinesApplicants.pdf\">Guidelines<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a href=\"https:\/\/www.eppermed.eu\/wp-content\/uploads\/2_EPPerMed_RITC2026_GuidelinesApplicants_FV.pdf\"><\/a><a href=\"https:\/\/www.eppermed.eu\/news-events\/events\/ep-permed-jtc2026-information-day\/\">Registro Infoday<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a href=\"https:\/\/registration.dlr-pt.de\/en\/ep-permed-ritc2026-information-day\/registration\"><\/a><a href=\"https:\/\/ptoutline.eu\/app\/EPPERMED2026\">Plataforma de env\u00edo de propuestas<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a href=\"https:\/\/ptoutline.eu\/app\/EPPERMEDRITC2026\"><\/a><a href=\"https:\/\/www.eppermed.eu\/wp-content\/uploads\/EPPerMed_JTC2026_CARMEN2026_pre-proposal_form.docx\">Template de pre-propuesta<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a href=\"https:\/\/www.eppermed.eu\/wp-content\/uploads\/EPPerMed_RITC_MultiPMData2026_pre-proposal_form.docx\"><\/a><a href=\"https:\/\/www.b2match.com\/e\/eppermed-partnering\">Plataforma de matchmaking<\/a><\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#195e7f\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_4,1_4,1_4,1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb50px||50px||true|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2023\/04\/Logoblancofondoazul.jpg\u00bb title_text=\u00bbLogoblancofondoazul\u00bb force_fullwidth=\u00bbon\u00bb _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb transform_scale_tablet=\u00bb202%|202%\u00bb transform_scale_phone=\u00bb202%|202%\u00bb transform_scale_last_edited=\u00bbon|tablet\u00bb transform_translate_tablet=\u00bb75px|25px\u00bb transform_translate_phone=\u00bb85px|-15px\u00bb transform_translate_last_edited=\u00bbon|phone\u00bb transform_translate_linked_tablet=\u00bboff\u00bb transform_rotate_tablet=\u00bb\u00bb transform_rotate_phone=\u00bb\u00bb transform_rotate_last_edited=\u00bbon|tablet\u00bb transform_skew_tablet=\u00bb\u00bb transform_skew_phone=\u00bb\u00bb transform_skew_last_edited=\u00bbon|tablet\u00bb transform_origin_tablet=\u00bb\u00bb transform_origin_phone=\u00bb\u00bb transform_origin_last_edited=\u00bbon|tablet\u00bb transform_styles_last_edited=\u00bbon|phone\u00bb min_height_tablet=\u00bb\u00bb min_height_phone=\u00bb\u00bb min_height_last_edited=\u00bbon|desktop\u00bb custom_margin_tablet=\u00bb||0px|-5px|false|false\u00bb custom_margin_phone=\u00bb||30px|-17px|false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb custom_padding=\u00bb|200px|||false|false\u00bb custom_padding_tablet=\u00bb0px|200px|||false|false\u00bb custom_padding_phone=\u00bb|200px|||false|false\u00bb custom_padding_last_edited=\u00bbon|desktop\u00bb transform_styles_tablet=\u00bb\u00bb transform_styles_phone=\u00bb\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.27.0&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb14px|||-11%|false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p class=\"x_MsoNormal\" style=\"text-align: left;\"><span style=\"color: #ffffff;\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px; float: left;\" \/>Avenida Severo Ochoa, 35, 29590, M\u00e1laga<\/span><\/p>\n<p style=\"color: #ffffff;\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/phone.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px;\" \/>952 36 76 00<\/p>\n<p><a href=\"mailto:info@ibima.eu\" data-linkindex=\"0\" id=\"LPlnk315329\"><img decoding=\"async\" src=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/email.png\" width=\"20\" style=\"position: relative; top: 3px; left: -5px;\" \/>info@ibima.eu<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][dsm_menu title=\u00bbAPARTADOS PRINCIPALES\u00bb menu_id=\u00bb1332&#8243; menu_link_text_color=\u00bb#FFFFFF\u00bb active_link_color=\u00bb#FFFFFF\u00bb menu_link_text_active_color=\u00bb#FFFFFF\u00bb menu_link_text_visited_color=\u00bb#FFFFFF\u00bb list_style_type=\u00bbnone\u00bb _builder_version=\u00bb4.24.0&#8243; _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins||||||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb20px\u00bb custom_margin_tablet=\u00bb200px||||false|false\u00bb custom_margin_phone=\u00bb0px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_menu][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][dsm_menu title=\u00bbTEXTOS LEGALES\u00bb menu_id=\u00bb1333&#8243; menu_link_text_color=\u00bb#FFFFFF\u00bb active_link_color=\u00bb#FFFFFF\u00bb menu_link_text_active_color=\u00bb#FFFFFF\u00bb menu_link_text_visited_color=\u00bb#FFFFFF\u00bb list_style_type=\u00bbnone\u00bb _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins||||||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb20px\u00bb custom_margin_tablet=\u00bb-155px||||false|false\u00bb custom_margin_phone=\u00bb0px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_menu][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.20.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_social_media_follow _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin_tablet=\u00bb5px||||false|false\u00bb custom_margin_phone=\u00bb5px||||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_social_media_follow_network social_network=\u00bbtwitter\u00bb url=\u00bbhttps:\/\/x.com\/_ibima?lang=es%20&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#000000&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]twitter[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbfacebook\u00bb url=\u00bbhttps:\/\/www.facebook.com\/Ibima.eu\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#3b5998&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]facebook[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbinstagram\u00bb url=\u00bbhttps:\/\/www.instagram.com\/ibima_mlg\/\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#ea2c59&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]instagram[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bblinkedin\u00bb url=\u00bbhttps:\/\/es.linkedin.com\/company\/ibima\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#007bb6&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]linkedin[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbyoutube\u00bb url=\u00bbhttps:\/\/www.youtube.com\/channel\/UCY3UUZTi9X0ur-1Gd6MKonw\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#a82400&#8243; global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]youtube[\/et_pb_social_media_follow_network][\/et_pb_social_media_follow][dsm_icon_list _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb custom_margin=\u00bb20px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbBuz\u00f3n de sugerencias\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/ibima.eu\/es\/comunicacion-con-el-instituto\/\u00bb url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][dsm_icon_list_child text=\u00bbBuz\u00f3n de denuncias\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/ibima.eu\/es\/canal-de-denuncias\/\u00bb url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][\/dsm_icon_list][dsm_icon_list _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins|600|||||||\u00bb custom_margin=\u00bb20px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][dsm_icon_list_child text=\u00bbSuscr\u00edbete al Canal de Divulgaci\u00f3n\u00bb font_icon=\u00bb&#x3d;||divi||400&#8243; icon_color=\u00bb#FFFFFF\u00bb url=\u00bbhttps:\/\/forms.gle\/5mczd4KKMqkBPdBy7&#8243; url_new_window=\u00bbon\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb][\/dsm_icon_list_child][\/dsm_icon_list][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La Asociaci\u00f3n Europea EP PerMed ha lanzado la convocatoria transnacional CARMEN2026, destinada a financiar proyectos de investigaci\u00f3n innovadora en medicina personalizada en el \u00e1mbito de las enfermedades cardiovasculares, metab\u00f3licas y renales, apoyada por la Uni\u00f3n Europea a trav\u00e9s de Horizon Europe. Esta iniciativa tiene como objetivo impulsar la competitividad europea mediante proyectos colaborativos que integren [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-58129","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EP PerMed - CARMEN2026 - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/es\/ep-permed-carmen2026\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EP PerMed - CARMEN2026 - Ibima\" \/>\n<meta property=\"og:description\" content=\"La Asociaci\u00f3n Europea EP PerMed ha lanzado la convocatoria transnacional CARMEN2026, destinada a financiar proyectos de investigaci\u00f3n innovadora en medicina personalizada en el \u00e1mbito de las enfermedades cardiovasculares, metab\u00f3licas y renales, apoyada por la Uni\u00f3n Europea a trav\u00e9s de Horizon Europe. Esta iniciativa tiene como objetivo impulsar la competitividad europea mediante proyectos colaborativos que integren [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/es\/ep-permed-carmen2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-27T09:25:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed-carmen2026\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed-carmen2026\\\/\",\"name\":\"EP PerMed - CARMEN2026 - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed-carmen2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed-carmen2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/contact.png\",\"datePublished\":\"2025-11-06T11:16:20+00:00\",\"dateModified\":\"2025-11-27T09:25:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed-carmen2026\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed-carmen2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed-carmen2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/contact.png\",\"contentUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/contact.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/ep-permed-carmen2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EP PerMed &#8211; CARMEN2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EP PerMed - CARMEN2026 - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/es\/ep-permed-carmen2026\/","og_locale":"es_ES","og_type":"article","og_title":"EP PerMed - CARMEN2026 - Ibima","og_description":"La Asociaci\u00f3n Europea EP PerMed ha lanzado la convocatoria transnacional CARMEN2026, destinada a financiar proyectos de investigaci\u00f3n innovadora en medicina personalizada en el \u00e1mbito de las enfermedades cardiovasculares, metab\u00f3licas y renales, apoyada por la Uni\u00f3n Europea a trav\u00e9s de Horizon Europe. Esta iniciativa tiene como objetivo impulsar la competitividad europea mediante proyectos colaborativos que integren [&hellip;]","og_url":"https:\/\/ibima.eu\/es\/ep-permed-carmen2026\/","og_site_name":"Ibima","article_modified_time":"2025-11-27T09:25:05+00:00","og_image":[{"url":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ibima.eu\/es\/ep-permed-carmen2026\/","url":"https:\/\/ibima.eu\/es\/ep-permed-carmen2026\/","name":"EP PerMed - CARMEN2026 - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ibima.eu\/es\/ep-permed-carmen2026\/#primaryimage"},"image":{"@id":"https:\/\/ibima.eu\/es\/ep-permed-carmen2026\/#primaryimage"},"thumbnailUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png","datePublished":"2025-11-06T11:16:20+00:00","dateModified":"2025-11-27T09:25:05+00:00","breadcrumb":{"@id":"https:\/\/ibima.eu\/es\/ep-permed-carmen2026\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/es\/ep-permed-carmen2026\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ibima.eu\/es\/ep-permed-carmen2026\/#primaryimage","url":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png","contentUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2024\/03\/contact.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/es\/ep-permed-carmen2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"EP PerMed &#8211; CARMEN2026"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/pages\/58129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/comments?post=58129"}],"version-history":[{"count":7,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/pages\/58129\/revisions"}],"predecessor-version":[{"id":58679,"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/pages\/58129\/revisions\/58679"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/es\/wp-json\/wp\/v2\/media?parent=58129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}